Upcoming Events

  1. PCT Amsterdam
  2. OC17

    9th Global OpenClinica Congress 2017

    December 4 - December 5

Register Today!

Get Free Test Access

Blog

Nov 2017

Implementing RBM – Moving out of your comfort zone

By | 2017-11-24T14:13:38+00:00 November 23, 2017|Blog, Library, Weekly RBM Feature, White Paper|0 Comments

  “There are always a million reasons not to do something” A great inspiring quote from Jan on an episode of The Office when Pam was making excuses not to go to Art school. A very recognisable habit, isn’t it? Talking ourselves out of [...]

Sep 2017

Generation of a Risk Report across Studies

By | 2017-10-10T17:05:02+00:00 September 18, 2017|Blog, Weekly RBM Feature|0 Comments

The RBM software EarlyBird® obtains a powerful and flexible system for ad-hoc reporting of risk-relevant data. It can be used to explore clinical data in more detail, prepare centralized monitoring reports, and build up a risk overview across studies. An example of such a [...]

Aug 2017

Predictive Analytics in RBM (cont.)

By | 2017-09-18T19:55:38+00:00 August 8, 2017|Blog, Library, RBM Product Updates, Weekly RBM Feature, White Paper|0 Comments

In our previous "predictive analytics in RBM" article, we started a discussion about algorithms of machine learning (ML), predictive analytics, and artificial intelligence. We also covered that a risk software needs to calculate forecasts of Key Risk Indicators (KRIs) proactively and alerts when they [...]

Aug 2017

Predictive Analytics in RBM

By | 2017-10-04T17:01:30+00:00 August 2, 2017|Blog, Library, Weekly RBM Feature, White Paper|0 Comments

Predictive analytics is a very useful tool in the risk-based monitoring and overall risk-based study management. It increases the proportion of correct decisions, as the decisions start being more data-driven. It also helps to understand for a central CRA or study manager the trending [...]

Apr 2017

Quality Tolerance Limits Video

By | 2017-05-10T20:04:09+00:00 April 19, 2017|Blog, Webinar|0 Comments

Video from our recent CyntegrityEDU Webinar - ICH E.6(GCP) Addendum Quality Tolerance Limits Part 1. ICH E6 background (Structural & Non-structural) Quality Tolerance Limits (QTLs) Brief history of QTLs How to use the QTLs Potential benefits Part 2. Technology consideration of QTLs Considerations of enabling [...]

Mar 2017

On what stage of RBM evolution is your company? There are four main stages…

By | 2017-10-04T16:54:16+00:00 March 31, 2017|Blog|0 Comments

Four stages of RBM Evolution in a Pharma Company Intelligent software systems are facilitating the data accumulation in clinical trials already. The 75% of clinical trials are conducted with the Electronic Data Capture (EDC) [1]. The next step is to unfreeze the knowledge of [...]

Dec 2016

Video from the Webinar “Risk-based Monitoring for Clinical Research Leaders”

By | 2016-12-20T19:48:09+00:00 December 20, 2016|Blog|0 Comments

The new Risk-based Monitoring concept reforms the clinical monitoring and clinical trial management. Risk factors become an important component there. What does it mean for a pharmaceutical company? Clinical trial risks are easy to foresee, site level risks and operational risks are hard to [...]

Nov 2016

RBM: innovation or just common sense?

By | 2016-11-24T10:01:15+00:00 November 24, 2016|Blog|0 Comments

The article covers the topics of clinical trial budgeting when applying the risk-based monitoring (RBM) model. The problem is that the new monitoring model requires a new model of clinical trial budgeting too, while today, the common practice is to apply traditional fixed-price budgeting. [...]

Nov 2016

The Emergence of a “Risk Monitor”: Preparing for the future.

By | 2016-11-16T18:35:28+00:00 November 9, 2016|Blog|0 Comments

Pharmaceutical companies and contract research organizations (CROs) are increasingly trying to leverage technology to optimize risk-based monitoring. While technology is a critical component, roles also need to be looked at again. Recently we interviewed Dr. Nimita Limaye, an expert in risk-based monitoring, about the future [...]